scispace - formally typeset
M

Miriam Almirall

Researcher at Autonomous University of Barcelona

Publications -  33
Citations -  425

Miriam Almirall is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Randomized controlled trial & Medicine. The author has an hindex of 11, co-authored 28 publications receiving 311 citations. Previous affiliations of Miriam Almirall include Hebron University.

Papers
More filters
Journal ArticleDOI

Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.

Xabier Michelena, +20 more
- 01 Aug 2020 - 
TL;DR: Adult and paediatric patients with rheumatic diseases on tDMARDs do not seem to present a higher risk of COVID-19 or a more severe disease outcome when compared to general population.
Journal ArticleDOI

Effectiveness of a Multicomponent Treatment for Fibromyalgia Based on Pain Neuroscience Education, Exercise Therapy, Psychological Support, and Nature Exposure (NAT-FM): A Pragmatic Randomized Controlled Trial.

Mayte Serrat, +7 more
- 18 Oct 2020 - 
TL;DR: Overall, TAU + NAT-FM was significantly more effective than TAU at posttreatment for the primary and secondary outcomes evaluated, as well as for the process variables.
Journal Article

Etanercept Reduces Synovitis as Measured by Magnetic Resonance Imaging in Patients with Active Rheumatoid Arthritis After Only 6 Weeks

María Pilar Lisbona, +5 more
- 01 Mar 2008 - 
TL;DR: In patients with active RA despite DMARD therapy, etanercept, but not placebo, reduced synovitis as measured by MRI after 6 weeks.
Journal ArticleDOI

Rapid reduction in tenosynovitis of the wrist and fingers evaluated by MRI in patients with rheumatoid arthritis after treatment with etanercept

María Pilar Lisbona, +4 more
- 01 Jun 2010 - 
TL;DR: Addition of etanercept significantly reduced MRI tenosynovitis of the wrist and fingers in patients with active rheumatoid arthritis refractory to DMARD treatment.
Journal ArticleDOI

Association of Bone Edema with the Progression of Bone Erosions Quantified by Hand Magnetic Resonance Imaging in Patients with Rheumatoid Arthritis in Remission

María Pilar Lisbona, +6 more
- 01 Aug 2014 - 
TL;DR: The persistence of higher scores of BME may explain the progression of bone erosions in patients with persistent clinical remission, and subclinical inflammation was identified by MRI in 96.4% of patients with RA in sustained clinical remission.